[1]
“Impact of Central Obesity on the Clinical and Biochemical Profile of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)”, mfm, vol. 36, no. 9, Oct. 2025, doi: 10.60110/medforum.360905.